These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33625407)

  • 1. Monitoring the neurotransmitter release of human midbrain organoids using a redox cycling microsensor as a novel tool for personalized Parkinson's disease modelling and drug screening.
    Zanetti C; Spitz S; Berger E; Bolognin S; Smits LM; Crepaz P; Rothbauer M; Rosser JM; Marchetti-Deschmann M; Schwamborn JC; Ertl P
    Analyst; 2021 Apr; 146(7):2358-2367. PubMed ID: 33625407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids.
    Renner H; Grabos M; Becker KJ; Kagermeier TE; Wu J; Otto M; Peischard S; Zeuschner D; TsyTsyura Y; Disse P; Klingauf J; Leidel SA; Seebohm G; Schöler HR; Bruder JM
    Elife; 2020 Nov; 9():. PubMed ID: 33138918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
    Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
    Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.
    Kim H; Park HJ; Choi H; Chang Y; Park H; Shin J; Kim J; Lengner CJ; Lee YK; Kim J
    Stem Cell Reports; 2019 Mar; 12(3):518-531. PubMed ID: 30799274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain organoids mimic early embryonic neurodevelopment and recapitulate LRRK2-p.Gly2019Ser-associated gene expression.
    Zagare A; Barmpa K; Smajic S; Smits LM; Grzyb K; Grünewald A; Skupin A; Nickels SL; Schwamborn JC
    Am J Hum Genet; 2022 Feb; 109(2):311-327. PubMed ID: 35077669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
    Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
    Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
    Marotta N; Kim S; Krainc D
    Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
    [No Abstract]   [Full Text] [Related]  

  • 8. Midbrain Organoids: A New Tool to Investigate Parkinson's Disease.
    Smits LM; Schwamborn JC
    Front Cell Dev Biol; 2020; 8():359. PubMed ID: 32509785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbon Fibers as a New Type of Scaffold for Midbrain Organoid Development.
    Tejchman A; Znój A; Chlebanowska P; Frączek-Szczypta A; Majka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.
    Monzel AS; Smits LM; Hemmer K; Hachi S; Moreno EL; van Wuellen T; Jarazo J; Walter J; Brüggemann I; Boussaad I; Berger E; Fleming RMT; Bolognin S; Schwamborn JC
    Stem Cell Reports; 2017 May; 8(5):1144-1154. PubMed ID: 28416282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining Automated Organoid Workflows with Artificial Intelligence-Based Analyses: Opportunities to Build a New Generation of Interdisciplinary High-Throughput Screens for Parkinson's Disease and Beyond.
    Renner H; Schöler HR; Bruder JM
    Mov Disord; 2021 Dec; 36(12):2745-2762. PubMed ID: 34498298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfabricated disk technology: Rapid scale up in midbrain organoid generation.
    Mohamed NV; Lépine P; Lacalle-Aurioles M; Sirois J; Mathur M; Reintsch W; Beitel LK; Fon EA; Durcan TM
    Methods; 2022 Jul; 203():465-477. PubMed ID: 34314827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
    Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Parkinson's disease in midbrain-like organoids.
    Smits LM; Reinhardt L; Reinhardt P; Glatza M; Monzel AS; Stanslowsky N; Rosato-Siri MD; Zanon A; Antony PM; Bellmann J; Nicklas SM; Hemmer K; Qing X; Berger E; Kalmbach N; Ehrlich M; Bolognin S; Hicks AA; Wegner F; Sterneckert JL; Schwamborn JC
    NPJ Parkinsons Dis; 2019; 5():5. PubMed ID: 30963107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microglia integration into human midbrain organoids leads to increased neuronal maturation and functionality.
    Sabate-Soler S; Nickels SL; Saraiva C; Berger E; Dubonyte U; Barmpa K; Lan YJ; Kouno T; Jarazo J; Robertson G; Sharif J; Koseki H; Thome C; Shin JW; Cowley SA; Schwamborn JC
    Glia; 2022 Jul; 70(7):1267-1288. PubMed ID: 35262217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling.
    Kwak TH; Kang JH; Hali S; Kim J; Kim KP; Park C; Lee JH; Ryu HK; Na JE; Jo J; Je HS; Ng HH; Kwon J; Kim NH; Hong KH; Sun W; Chung CH; Rhyu IJ; Han DW
    Stem Cells; 2020 Jun; 38(6):727-740. PubMed ID: 32083763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-Derived Midbrain Organoids to Explore the Molecular Basis of Parkinson's Disease.
    Galet B; Cheval H; Ravassard P
    Front Neurol; 2020; 11():1005. PubMed ID: 33013664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental defects and neurodegenerative phenotypes in human brain organoids carrying Parkinson's disease-linked
    Wulansari N; Darsono WHW; Woo HJ; Chang MY; Kim J; Bae EJ; Sun W; Lee JH; Cho IJ; Shin H; Lee SJ; Lee SH
    Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
    Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
    J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.